Insight on mutation-induced resistance to anaplastic lymphoma kinase inhibitor ceritinib from molecular dynamics simulations.

He MY, Li WK, Meiler J, Zheng QC, Zhang HX
Biopolymers. 2019 110 (2): e23257

PMID: 30664251 · DOI:10.1002/bip.23257

MeSH Terms (13)

Adenosine Triphosphate Anaplastic Lymphoma Kinase Binding Sites Drug Resistance, Neoplasm Humans Molecular Dynamics Simulation Mutagenesis, Site-Directed Neoplasms Principal Component Analysis Protein Kinase Inhibitors Protein Structure, Tertiary Pyrimidines Sulfones

Connections (1)

This publication is referenced by other Labnodes entities:

Links